Memory Gel and Shape Combined Cohort
NCT02919592 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3603
Last updated 2026-05-08
Summary
The purpose of this study is to collect additional post-approval clinical data on the long-term performance of MemoryShape and MemoryGel Breast Implants, as indicated for primary or revisional breast augmentation and primary or revisional breast reconstruction.
Conditions
- Primary Breast Augmentation
- Primary Breast Reconstruction
- Revision Breast Augmentation
- Revision Breast Reconstruction
Interventions
- DEVICE
-
MemoryShape® Breast Implants
MENTOR® MemoryShape™ Breast Implants are devices with shells constructed from medical grade silicone elastomer. The shell is filled with Mentor's proprietary formulation of medical grade silicone gel. The textured shell is constructed of successive crosslinked layers of silicone elastomer, and includes raised orientation marks on the anterior and posterior of the implant intended to help the physician orient the implant and ensure proper placement during implantation. Each MENTOR® MemoryShape™ Breast Implant is provided sterile. MemoryShape Breast Implants are available in sizes ranging from 120 cc-775 cc and 5 styles with various projection and height options.
- DEVICE
-
MemoryGel® Breast Implants
MENTOR® MemoryGel™ Breast Implants are round devices with shells constructed from medical grade silicone elastomer. The shell is filled with MemoryGel™, Mentor's proprietary formulation of medical grade silicone gel, and is constructed of successive cross-linked layers of silicone elastomer. There are two styles of shell: smooth and textured. Each MENTOR® MemoryGel™ Breast Implant is provided sterile. MemoryGel Breast Implants are available in sizes ranging from 100 cc-800 cc and 4 styles with various projection and height options.
- PROCEDURE
-
Other Aesthetic Surgery
Other aesthetic surgery procedures (for example, liposuction, rhinoplasty, brow lift, rhytidectomy, mentoplasty/genioplasty, otoplasty, or blepharoplasty; may not include silicone implants)
Sponsors & Collaborators
-
Mentor Worldwide, LLC
lead INDUSTRY
Principal Investigators
-
Medical Director · Mentor Worldwide, LLC
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2031-09-16
- Completion
- 2031-09-16
Countries
- United States
Study Locations
More Related Trials
-
Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos
NCT02110095 ·Status: COMPLETED ·Phase: NA
-
A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC
NCT06360952 ·Status: NOT_YET_RECRUITING
-
A Study of a Novel Multi-Wavelength Laser for Tattoo Removal
NCT02910505 ·Status: COMPLETED ·Phase: NA
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
NCT01754207 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Evaluation of the StarGuide Next Generation SPECT/CT System
NCT07272161 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A 5 Year Clinical Investigation on Creos Xenoprotect
NCT02373787 ·Status: TERMINATED ·Phase: NA
-
Electromagnetic Tracking of Devices During Interventional Procedures
NCT01279148 ·Status: WITHDRAWN
-
Evaluation by Magnetic Resonance Imaging of Intramuscular Injections Performance in Thigh With 2 Configurations of the Needle-free Injector ZENEO®.
NCT05967013 ·Status: COMPLETED ·Phase: NA
-
An Investigation to Evaluate Wearing Properties of Three Different Investigational Devices
NCT07034014 ·Status: RECRUITING ·Phase: NA
-
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning
NCT05743842 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
NCT01672086 ·Status: TERMINATED
-
Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis
NCT02140905 ·Status: COMPLETED
-
The Lumen Study: Comparing Devices for Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO)
NCT02145299 ·Status: TERMINATED ·Phase: PHASE2
-
Multi-Wavelength Laser Tattoo Removal Pivotal Study
NCT02935660 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
NCT05740644 ·Status: COMPLETED ·Phase: NA
-
Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
NCT02176239 ·Status: COMPLETED
-
Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter
NCT02349308 ·Status: COMPLETED
-
Safety and Efficacy Study of the SoundBite™ Crossing System With ACTIVE Wire in Coronary CTOs.
NCT03521804 ·Status: TERMINATED ·Phase: NA
-
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT00754091 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Applications of the Given® Diagnostic System and Evaluation of Their Performance
NCT00949208 ·Status: COMPLETED
-
Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600
NCT05463198 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.
NCT06697223 ·Status: COMPLETED ·Phase: PHASE2
-
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
NCT02756234 ·Status: COMPLETED